Sigma-receptor ligands and anti-stress actions

Y. Noda, H. Kamei, Toshitaka Nabeshima

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The functional role of sigma receptors in the central nervous system has been investigated extensively. Sigma1-receptors have been shown to play an important role in antidepressive effects since selective sigma1-receptor agonists, as well as typical antidepressants, reduced the immobility time in the forced swimming and tail suspension tests. The reduction of immobility by sigma1-receptor agonists is antagonized by NE-100, a sigma1-receptor antagonist. It has been suggested that sigma receptors are involved in anxiety since Lu 28-179, a sigma2-receptor agonist, has anxiolytic properties in rodents. In addition to the depressive animal model, phenytoin- sensitive sigma1-receptor agonists such as (+)-SKF-10,047 and dextromethorphan attenuate the conditioned fear stress (CFS) response (which is not influenced by typical anxiolytics and antidepressants) in rodents, the attenuating effects being mediated through phenytoinsensitive sigma1receptors, which are closely connected to the mesolimbic dopaminergic systems. Furthermore, neurosteroids such as dehydroepiandrosterone sulfate also attenuate the CFS response, the effect being mediated via sigma1 receptors. These findings suggest that sigma receptors are involved in stress-induced pathophysiological changes such as depression and anxiety and that phenytoin-sensitive sigma1-receptor ligands are useful for the treatment of affective disorders, particularly those considered to be treatment-resistant.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalFolia Pharmacologica Japonica
Volume114
Issue number1
Publication statusPublished - 27-07-1999

Fingerprint

sigma Receptors
Anti-Anxiety Agents
Phenytoin
Ligands
Antidepressive Agents
Fear
Rodentia
Anxiety
Dextromethorphan
Hindlimb Suspension
Dehydroepiandrosterone Sulfate
Mood Disorders
Neurotransmitter Agents
Central Nervous System
Animal Models
Depression
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Noda, Y. ; Kamei, H. ; Nabeshima, Toshitaka. / Sigma-receptor ligands and anti-stress actions. In: Folia Pharmacologica Japonica. 1999 ; Vol. 114, No. 1. pp. 43-49.
@article{a5af7fe0465946d5b77bb0c1019f6825,
title = "Sigma-receptor ligands and anti-stress actions",
abstract = "The functional role of sigma receptors in the central nervous system has been investigated extensively. Sigma1-receptors have been shown to play an important role in antidepressive effects since selective sigma1-receptor agonists, as well as typical antidepressants, reduced the immobility time in the forced swimming and tail suspension tests. The reduction of immobility by sigma1-receptor agonists is antagonized by NE-100, a sigma1-receptor antagonist. It has been suggested that sigma receptors are involved in anxiety since Lu 28-179, a sigma2-receptor agonist, has anxiolytic properties in rodents. In addition to the depressive animal model, phenytoin- sensitive sigma1-receptor agonists such as (+)-SKF-10,047 and dextromethorphan attenuate the conditioned fear stress (CFS) response (which is not influenced by typical anxiolytics and antidepressants) in rodents, the attenuating effects being mediated through phenytoinsensitive sigma1receptors, which are closely connected to the mesolimbic dopaminergic systems. Furthermore, neurosteroids such as dehydroepiandrosterone sulfate also attenuate the CFS response, the effect being mediated via sigma1 receptors. These findings suggest that sigma receptors are involved in stress-induced pathophysiological changes such as depression and anxiety and that phenytoin-sensitive sigma1-receptor ligands are useful for the treatment of affective disorders, particularly those considered to be treatment-resistant.",
author = "Y. Noda and H. Kamei and Toshitaka Nabeshima",
year = "1999",
month = "7",
day = "27",
language = "English",
volume = "114",
pages = "43--49",
journal = "Folia Pharmacologica Japonica",
issn = "0015-5691",
publisher = "Japanese Pharmacological Society",
number = "1",

}

Sigma-receptor ligands and anti-stress actions. / Noda, Y.; Kamei, H.; Nabeshima, Toshitaka.

In: Folia Pharmacologica Japonica, Vol. 114, No. 1, 27.07.1999, p. 43-49.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sigma-receptor ligands and anti-stress actions

AU - Noda, Y.

AU - Kamei, H.

AU - Nabeshima, Toshitaka

PY - 1999/7/27

Y1 - 1999/7/27

N2 - The functional role of sigma receptors in the central nervous system has been investigated extensively. Sigma1-receptors have been shown to play an important role in antidepressive effects since selective sigma1-receptor agonists, as well as typical antidepressants, reduced the immobility time in the forced swimming and tail suspension tests. The reduction of immobility by sigma1-receptor agonists is antagonized by NE-100, a sigma1-receptor antagonist. It has been suggested that sigma receptors are involved in anxiety since Lu 28-179, a sigma2-receptor agonist, has anxiolytic properties in rodents. In addition to the depressive animal model, phenytoin- sensitive sigma1-receptor agonists such as (+)-SKF-10,047 and dextromethorphan attenuate the conditioned fear stress (CFS) response (which is not influenced by typical anxiolytics and antidepressants) in rodents, the attenuating effects being mediated through phenytoinsensitive sigma1receptors, which are closely connected to the mesolimbic dopaminergic systems. Furthermore, neurosteroids such as dehydroepiandrosterone sulfate also attenuate the CFS response, the effect being mediated via sigma1 receptors. These findings suggest that sigma receptors are involved in stress-induced pathophysiological changes such as depression and anxiety and that phenytoin-sensitive sigma1-receptor ligands are useful for the treatment of affective disorders, particularly those considered to be treatment-resistant.

AB - The functional role of sigma receptors in the central nervous system has been investigated extensively. Sigma1-receptors have been shown to play an important role in antidepressive effects since selective sigma1-receptor agonists, as well as typical antidepressants, reduced the immobility time in the forced swimming and tail suspension tests. The reduction of immobility by sigma1-receptor agonists is antagonized by NE-100, a sigma1-receptor antagonist. It has been suggested that sigma receptors are involved in anxiety since Lu 28-179, a sigma2-receptor agonist, has anxiolytic properties in rodents. In addition to the depressive animal model, phenytoin- sensitive sigma1-receptor agonists such as (+)-SKF-10,047 and dextromethorphan attenuate the conditioned fear stress (CFS) response (which is not influenced by typical anxiolytics and antidepressants) in rodents, the attenuating effects being mediated through phenytoinsensitive sigma1receptors, which are closely connected to the mesolimbic dopaminergic systems. Furthermore, neurosteroids such as dehydroepiandrosterone sulfate also attenuate the CFS response, the effect being mediated via sigma1 receptors. These findings suggest that sigma receptors are involved in stress-induced pathophysiological changes such as depression and anxiety and that phenytoin-sensitive sigma1-receptor ligands are useful for the treatment of affective disorders, particularly those considered to be treatment-resistant.

UR - http://www.scopus.com/inward/record.url?scp=0032778431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032778431&partnerID=8YFLogxK

M3 - Article

C2 - 10562964

AN - SCOPUS:0032778431

VL - 114

SP - 43

EP - 49

JO - Folia Pharmacologica Japonica

JF - Folia Pharmacologica Japonica

SN - 0015-5691

IS - 1

ER -